Dr. Huntington Potter, CU Anschutz Medical Campus professor and director of the Rocky Mountain Alzheimer’s Disease Center, speaks with CU’s Ken McConnellogue about: - The drug leukine, which shows encouraging results - Why Down syndrome research is important in Alzheimer’s research - What the center is looking for in clinical studies
No transcript available.